Enhanced expression of codon optimized interferon gamma in CHO cells

Journal of Biotechnology

Volumn 167, Issue 3, 2013, Pages 326-333

  Chung, Bevan Kai Sheng ^a   Yusufi, Faraaz N K ^a   Mariati, ^a   Yang, Yuansheng ^a,b   Lee, Dong Yup ^a,c  

^a AGENCY FOR SCIENCE   (Singapore)

^b Nanyang Technological University   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Chinese hamster ovary cells; Codon context; Codon optimization; Interferon gamma; Recombinant protein production; Synthetic gene design

Indexed keywords

CHINESE HAMSTER OVARY CELLS; CODON CONTEXT; CODON OPTIMIZATION; INTERFERON-GAMMA; RECOMBINANT PROTEIN PRODUCTIONS; SYNTHETIC GENES;

ANTIBIOTICS; CELLS; CYTOLOGY; DESIGN; ESCHERICHIA COLI; GLYCOPROTEINS; OPTIMIZATION; RECOMBINANT PROTEINS; YEAST;

GENE EXPRESSION;

GAMMA INTERFERON; TRANSCRIPTOME; CODON; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CODON; CODON USAGE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; HETEROLOGOUS EXPRESSION; HOST; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RNA SEQUENCE; SACCHAROMYCES CEREVISIAE; WILD TYPE; ANIMAL; CHO CELL LINE; CRICETULUS; GENETICS; HAMSTER; METABOLISM; PROCEDURES; PROTEIN ENGINEERING;

ANIMALS; CHO CELLS; CODON; CRICETINAE; CRICETULUS; GENE EXPRESSION PROFILING; INTERFERON-GAMMA; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 84881517685     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2013.07.011     Document Type: Article

References (28)

1. Cheng A.A., Lu T.K. Synthetic biology: an emerging engineering discipline. Annual Review of Biomedical Engineering 2012, 14:155-178.
2. Chu L., Robinson D.K. Industrial choices for protein production by large-scale cell culture. Current Opinion in Biotechnology 2001, 12:180-187.
3. Chung B.K., Lee D.Y. Computational codon optimization of synthetic gene for protein expression. BMC Systems Biology 2012, 6:134.
4. Fu S., Fan J., Blanco J., Gimenez-Cassina A., Danial N.N., Watkins S.M., Hotamisligil G.S. Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting. PLOS Genetics 2012, 8:e1002902.
5. Fu X., Fu N., Guo S., Yan Z., Xu Y., Hu H., Menzel C., Chen W., Li Y., Zeng R., Khaitovich P. Estimating accuracy of RNA-Seq and microarrays with proteomics. BMC Genomics 2009, 10:161.
6. Gustafsson C., Govindarajan S., Minshull J. Codon bias and heterologous protein expression. Trends in Biotechnology 2004, 22:346-353.
7. Halbeisen R.E., Gerber A.P. Stress-dependent coordination of transcriptome and translatome in yeast. PLOS Biology 2009, 7:e1000105.
8. Hershberg R., Petrov D.A. Selection on codon bias. Annual Review of Genetics 2008, 42:287-299.
9. Karlin S., Mrazek J., Campbell A.M. Codon usages in different gene classes of the Escherichia coli genome. Molecular Microbiology 1998, 29:1341-1355.
10. Kim C.H., Oh Y., Lee T.H. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. Gene 1997, 199:293-301.
11. Kurland C., Gallant J. Errors of heterologous protein expression. Current Opinion in Biotechnology 1996, 7:489-493.
12. Lim L.H., Li H.Y., Cheong N., Lee B.W., Chua K.Y. High-level expression of a codon optimized recombinant dust mite allergen, Blo t 5, in Chinese hamster ovary cells. Biochemical and Biophysical Research Communications 2004, 316:991-996.
13. Menzella H.G. Comparison of two codon optimization strategies to enhance recombinant protein production in Escherichia coli. Microbial Cell Factories 2011, 10:15.
14. Miller C.H., Maher S.G., Young H.A. Clinical use of interferon-gamma. Annals of the New York Academy of Sciences 2009, 1182:69-79.
15. Moore B. Principal component analysis in linear systems: controllability, observability, and model reduction. IEEE Transactions on Automatic Control 1981, 26:17-32.
16. Muir A.J., Sylvestre P.B., Rockey D.C. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection. Journal of Viral Hepatitis 2006, 13:322-328.
17. Sareneva T., Cantell K., Pyhala L., Pirhonen J., Julkunen I. Effect of carbohydrates on the pharmacokinetics of human interferon-gamma. Journal of Interferon Research 1993, 13:267-269.
18. Sareneva T., Pirhonen J., Cantell K., Julkunen I. N-glycosylation of human interferon-gamma: glycans at Asn-25 are critical for protease resistance. Biochemical Journal 1995, 308(Pt 1):9-14.
19. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. Journal of Leukocyte Biology 2004, 75:163-189.
20. Sharp P.M., Cowe E., Higgins D.G., Shields D.C., Wolfe K.H., Wright F. Codon usage patterns in Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster and Homo sapiens: a review of the considerable within-species diversity. Nucleic Acids Research 1988, 16:8207-8211.
21. Sharp P.M., Li W.H. The codon adaptation index--a measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Research 1987, 15:1281-1295.
22. Suarez-Mendez R., Garcia-Garcia I., Fernandez-Olivera N., Valdes-Quintana M., Milanes-Virelles M.T., Carbonell D., Machado-Molina D., Valenzuela-Silva C.M., Lopez-Saura P.A. Adjuvant interferon gamma in patients with drug-resistant pulmonary tuberculosis: a pilot study. BMC Infectious Diseases 2004, 4:44.
23. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., van Baren M.J., Salzberg S.L., Wold B.J., Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature Biotechnology 2010, 28:511-515.
24. Vilcek J., Feldmann M. Historical review: cytokines as therapeutics and targets of therapeutics. Trends in Pharmacological Sciences 2004, 25:201-209.
25. Welch M., Govindarajan S., Ness J.E., Villalobos A., Gurney A., Minshull J., Gustafsson C. Design parameters to control synthetic gene expression in Escherichia coli. PLoS One 2009, 4:e7002.
26. Welch M., Villalobos A., Gustafsson C., Minshull J. You're one in a googol: optimizing genes for protein expression. Journal of the Royal Society Interface 2009, 6(Suppl 4):S467-S476.
27. Windbichler G.H., Hausmaninger H., Stummvoll W., Graf A.H., Kainz C., Lahodny J., Denison U., Muller-Holzner E., Marth C. Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial. British Journal of Cancer 2000, 82:1138-1144.
28. Xu X., Nagarajan H., Lewis N.E., Pan S., Cai Z., Liu X., Chen W., Xie M., Wang W., Hammond S., Andersen M.R., Neff N., Passarelli B., Koh W., Fan H.C., Wang J., Gui Y., Lee K.H., Betenbaugh M.J., Quake S.R., Famili I., Palsson B.O. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nature Biotechnology 2011, 29:735-741.